Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Philippines Accused Of Bribery For Offering 5 Million Discount Cards

This article was originally published in PharmAsia News

Executive Summary

The head of the Philippines Senate accused Pfizer Philippines of attempting to bribe the government to circumvent the nation's new drug-pricing law. The allegation is an interpretation of Pfizer's offer to provide 5 million discount cards to the Department of Health, mainly for the company's Norvasc (amlodipine) for treating hypertension. The head of the Pharmaceutical and Healthcare Association of the Philippines revealed the offer, which he said was made before the department set maximum retail prices for 22 drugs. The department rejected the company's offer, but the Senate president said it was an attempt to bribe the government into blocking enforcement of the Quality Affordable Medicine Law. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072168

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel